Biogen Inc (BIIB) is trading at $190.49 down 8.87% over the past 24 hours. Its Galaxy Score is 68.7, LunarCrush's combined measure of market and social performance. Over the last 24 hours it has seen 95.6K engagements and 209 posts with 91% positive social sentiment.
AI summary: Biogen Inc. is a biotech stock centered on LEQEMBI and related Alzheimer's collaborations. Optimism around LEQEMBI home-dose approval and Apellis collaboration supports upside, but price gains appear capped by deal premium and longer-term patent risk, likely maintaining a choppy action ahead of milestones.
Biogen Inc (BIIB) is tracked on LunarCrush, where you can follow its price alongside live social activity and sentiment across X, Reddit, YouTube and other networks.
Biogen Inc (BIIB) is trading at $190.49, down 8.87% over the past 24 hours.
$BIIB has a Galaxy Score of 68.7 — LunarCrush's 0–100 measure combining an asset's market and social performance.
Yes. $BIIB social sentiment is 91% positive across social posts over the last 24 hours.
There have been 209 posts about $BIIB over the last 24 hours.
On LunarCrush — follow $BIIB's real-time social sentiment, engagement and market activity across X, Reddit, YouTube, TikTok and news in one place.